Popular CT scans could account for 5% of all cancer cases a year

(Press-News.org) Popular CT Scans Could Account for 5% of All Cancer Cases A Year 
Radiation from imaging could lead to lung, breast and other future cancers, with 10-fold increased risk for babies  

CT scans may account for 5% of all cancers annually, according to a new study out of UC San Francisco that cautions against overusing and overdosing CTs.  

The danger is greatest for infants, followed by children and adolescents. But adults also are at risk, since they are the most likely to get scans.  

Nearly 103,000 cancers are predicted to result from the 93 million CTs that were performed in 2023 alone. This is 3 to 4 times more than previous assessments, the authors said.  

The study, which was funded by the National Institutes of Health, appears April 14 in JAMA Internal Medicine.  

“CT can save lives, but its potential harms are often overlooked,” said first author Rebecca Smith-Bindman, MD, a UCSF radiologist and professor of epidemiology and biostatistics and obstetrics, gynecology and reproductive sciences.  

“Given the large volume of CT use in the United States, many cancers could occur in the future if current practices don’t change,” said Smith-Bindman, who is also a member of the Philip R. Lee Institute for Health Policy Studies and directs the Radiology Outcomes Research Lab.  

“Our estimates put CT on par with other significant risk factors, such as alcohol consumption and excess body weight,” she said. “Reducing the number of scans and reducing doses per scan would save lives.” 

Benefits and potential dangers  

Computed tomography (CT) is both indispensable and widely used to detect tumors and diagnose many illnesses. Since 2007, the number of annual CT exams has surged by 30% in the U.S.  

But CTs expose patients to ionizing radiation – a carcinogen – and it’s long been known that the technology carries a higher risk of cancer. 

To assess the public health impact of current CT use, Smith-Bindman's study estimates the total number of lifetime cancers associated with radiation exposure in relation to the number and type of CT scans performed in 2023. 

Researchers analyzed 93 million exams from 61.5 million patients in the U.S. The number of scans increased with age, peaking in adults between 60 to 69 years old. Children accounted for 4.2% of the scans. The researchers excluded tests in the patient’s last year of life because it was unlikely to lead to cancer. 

Future cancers from radiation exposure 

Adults 50 to 59 had the highest number of projected cancers: 10,400 cases to women, 9,300 to men.  

The most common adult cancers were lung, colon, leukemia, bladder and breast. The most frequently projected cancers in children were thyroid, lung and breast.  

The largest number of cancers in adults would come from CTs of the abdomen and pelvis, while in children they came from CTs of the head. Projected cancer risks were highest among those who underwent CT when they were under 1 year old. They were 10 times more likely to get cancer compared to others in the study.  

The researchers said some CT scans are unlikely to help patients and are overused, such as those for upper respiratory infections or for headaches without concerning signs or symptoms. They said patients could lower their risk by getting fewer of these scans, or by getting lower dose scans.  

“There is currently unacceptable variation in the doses used for CT, with some patients receiving excessive doses,” Smith-Bindman said.  

Co-author Malini Mahendra, MD, a UCSF assistant professor of Pediatric Critical Care, said it was important that families understand the risk of developing cancer from pediatric scans. 

“Few patients and their families are counseled about the risk associated with CT examinations,” she said. “We hope our study’s findings will help clinicians better quantify and communicate these cancer risks, allowing for more informed conversations when weighing the benefits and risks of CT exams.” 

Authors: From UCSF, authors are Philip W. Chu; Hana Azman Firdaus; Carly Stewart; Matthew Malekhedayat; and Malini Mahendra, MD. Joint senior authors are Diana L. Miglioretti, PhD, of UC Davis and Kaiser Permanente Washington Health Research Institute, and Amy Berrington de Gonzalez, DPhil, of The Institute of Cancer Research, London. Other authors are Susan Alber, PhD, of UC Davis; and Wesley E. Bolch, PhD of the University of Florida.  

Disclosures: Please see the paper.  

Funding: The research was supported in part by awards from the National Cancer Institute (1R01CA181191-O1A1), the Patient-Centered Outcomes Research Institute (CD-1304-7043).  

 

About UCSF: The University of California, San Francisco (UCSF) is exclusively focused on the health sciences and is dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF Health, which serves as UCSF's primary academic medical center, includes top-ranked specialty hospitals and other clinical programs, and has affiliations throughout the Bay Area. UCSF School of Medicine also has a regional campus in Fresno. Learn more at ucsf.edu, or see our Fact Sheet.

###

 

END